MBRX · Moleculin Biotech, Inc. · Documents
$6.50
+0.61 (+10.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.33M
Shares
973,869
Volume · Oct 23
27.74K
Avg daily vol (4 sessions)
65.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-05-05 | — | |
| 8-K | — | 2023-05-04 | — | |
| 8-K | — | 2023-05-02 | — | |
| 8-K | — | 2023-04-18 | — | |
| DEFA14A | — | 2023-04-13 | — | |
| DEF 14A | — | 2023-04-13 | 2023-05-25 | |
| 8-K | — | 2023-04-03 | — | |
| PRE 14A | — | 2023-04-03 | 2023-05-25 | |
| 8-K | — | 2023-03-23 | — | |
| 10-K | — | 2023-03-22 | 2022-12-31 | |
| 8-K | — | 2023-03-22 | — | |
| 8-K | — | 2023-03-15 | — | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-03-09 | — | |
| 8-K | — | 2023-03-01 | — | |
| 8-K | — | 2023-02-13 | — | |
| 8-K | — | 2023-02-08 | — | |
| 8-K | — | 2023-02-03 | — | |
| 8-K | — | 2022-12-21 | — | |
| 8-K | — | 2022-12-15 | — | |
| 8-K | — | 2022-12-07 | — | |
| 8-K | — | 2022-11-14 | 2022-11-10 | |
| 8-K | — | 2022-11-10 | — | |
| 10-Q | — | 2022-11-10 | 2022-09-30 | |
| 8-K | — | 2022-10-14 | — | |
| 8-K | — | 2022-09-27 | — | |
| 8-K | — | 2022-09-09 | — | |
| 8-K | — | 2022-09-06 | — | |
| 8-K | — | 2022-08-19 | — | |
| 8-K | — | 2022-08-18 | — | |
| 8-K | — | 2022-08-15 | — | |
| 10-Q | — | 2022-08-12 | 2022-06-30 | |
| 8-K | — | 2022-07-28 | — | |
| 8-K | — | 2022-07-08 | — | |
| 8-K | — | 2022-06-16 | — | |
| 8-K | — | 2022-06-09 | — | |
| 8-K | — | 2022-05-31 | 2022-05-26 | |
| 8-K | — | 2022-05-26 | — | |
| 8-K | — | 2022-05-20 | — | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-11 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| 8-K | — | 2022-05-05 | — | |
| 8-K | — | 2022-05-04 | — | |
| 8-K | — | 2022-04-21 | — | |
| DEF 14A | — | 2022-04-14 | 2022-05-26 | |
| 8-K/A | — | 2022-04-12 | 2022-04-08 | |
| 8-K | — | 2022-04-08 | — | |
| PRE 14A | — | 2022-04-04 | 2022-05-26 | |
| 8-K | — | 2022-03-25 | — |
Showing 251–300 of 407 filings